New insights on congenital pulmonary airways malformations revealed by proteomic analyses

Abstract Background Congenital Pulmonary Airway Malformation (CPAM) has an estimated prevalence between 0.87 and 1.02/10,000 live births and little is know about their pathogenesis. To improve our knowledge on these rare malformations, we analyzed the cellular origin of the two most frequent CPAM, C...

Full description

Bibliographic Details
Main Authors: C. Barazzone-Argiroffo, J. Lascano Maillard, I. Vidal, M. L. Bochaton-Piallat, S. Blaskovic, Y. Donati, B. E. Wildhaber, A.-L. Rougemont, C. Delacourt, I. Ruchonnet-Métrailler
Format: Article
Language:English
Published: BMC 2019-11-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Online Access:https://doi.org/10.1186/s13023-019-1192-4
_version_ 1818969014762733568
author C. Barazzone-Argiroffo
J. Lascano Maillard
I. Vidal
M. L. Bochaton-Piallat
S. Blaskovic
Y. Donati
B. E. Wildhaber
A.-L. Rougemont
C. Delacourt
I. Ruchonnet-Métrailler
author_facet C. Barazzone-Argiroffo
J. Lascano Maillard
I. Vidal
M. L. Bochaton-Piallat
S. Blaskovic
Y. Donati
B. E. Wildhaber
A.-L. Rougemont
C. Delacourt
I. Ruchonnet-Métrailler
author_sort C. Barazzone-Argiroffo
collection DOAJ
description Abstract Background Congenital Pulmonary Airway Malformation (CPAM) has an estimated prevalence between 0.87 and 1.02/10,000 live births and little is know about their pathogenesis. To improve our knowledge on these rare malformations, we analyzed the cellular origin of the two most frequent CPAM, CPAM types 1 and 2, and compared these malformations with adjacent healthy lung and human fetal lungs. Methods We prospectively enrolled 21 infants undergoing surgical resection for CPAM. Human fetal lung samples were collected after termination of pregnancy. Immunohistochemistry and proteomic analysis were performed on laser microdissected samples. Results CPAM 1 and 2 express mostly bronchial markers, such as cytokeratin 17 (Krt17) or α-smooth muscle actin (ACTA 2). CPAM 1 also expresses alveolar type II epithelial cell markers (SPC). Proteomic analysis on microlaser dissected epithelium confirmed these results and showed distinct protein profiles, CPAM 1 being more heterogeneous and displaying some similarities with fetal bronchi. Conclusion This study provides new insights in CPAM etiology, showing clear distinction between CPAM types 1 and 2, by immunohistochemistry and proteomics. This suggests that CPAM 1 and CPAM 2 might occur at different stages of lung branching. Finally, the comparison between fetal lung structures and CPAMs shows clearly different protein profiles, thereby arguing against a developmental arrest in a localized part of the lung.
first_indexed 2024-12-20T14:13:51Z
format Article
id doaj.art-eb461c76afbc4da78fde2d48d1ed4b16
institution Directory Open Access Journal
issn 1750-1172
language English
last_indexed 2024-12-20T14:13:51Z
publishDate 2019-11-01
publisher BMC
record_format Article
series Orphanet Journal of Rare Diseases
spelling doaj.art-eb461c76afbc4da78fde2d48d1ed4b162022-12-21T19:38:06ZengBMCOrphanet Journal of Rare Diseases1750-11722019-11-0114111310.1186/s13023-019-1192-4New insights on congenital pulmonary airways malformations revealed by proteomic analysesC. Barazzone-Argiroffo0J. Lascano Maillard1I. Vidal2M. L. Bochaton-Piallat3S. Blaskovic4Y. Donati5B. E. Wildhaber6A.-L. Rougemont7C. Delacourt8I. Ruchonnet-Métrailler9Pediatric Pulmonology Unit, Department of Pediatrics,Obstetrics and Gynecology, Children’s HospitalDepartment of Pathology and Immunology, Faculty of Medicine, University of GenevaDivision of Pediatric Surgery, University Hospitals Geneva, University Center of Pediatric Surgery of Western SwitzerlandDepartment of Pathology and Immunology, Faculty of Medicine, University of GenevaDepartment of Pathology and Immunology, Faculty of Medicine, University of GenevaDepartment of Pathology and Immunology, Faculty of Medicine, University of GenevaDivision of Pediatric Surgery, University Hospitals Geneva, University Center of Pediatric Surgery of Western SwitzerlandDivision of Clinical Pathology, Geneva University HospitalsAP-HP, Hôpital Necker-Enfants Malades, Service de Pneumologie et Allergologie PédiatriquesPediatric Pulmonology Unit, Department of Pediatrics,Obstetrics and Gynecology, Children’s HospitalAbstract Background Congenital Pulmonary Airway Malformation (CPAM) has an estimated prevalence between 0.87 and 1.02/10,000 live births and little is know about their pathogenesis. To improve our knowledge on these rare malformations, we analyzed the cellular origin of the two most frequent CPAM, CPAM types 1 and 2, and compared these malformations with adjacent healthy lung and human fetal lungs. Methods We prospectively enrolled 21 infants undergoing surgical resection for CPAM. Human fetal lung samples were collected after termination of pregnancy. Immunohistochemistry and proteomic analysis were performed on laser microdissected samples. Results CPAM 1 and 2 express mostly bronchial markers, such as cytokeratin 17 (Krt17) or α-smooth muscle actin (ACTA 2). CPAM 1 also expresses alveolar type II epithelial cell markers (SPC). Proteomic analysis on microlaser dissected epithelium confirmed these results and showed distinct protein profiles, CPAM 1 being more heterogeneous and displaying some similarities with fetal bronchi. Conclusion This study provides new insights in CPAM etiology, showing clear distinction between CPAM types 1 and 2, by immunohistochemistry and proteomics. This suggests that CPAM 1 and CPAM 2 might occur at different stages of lung branching. Finally, the comparison between fetal lung structures and CPAMs shows clearly different protein profiles, thereby arguing against a developmental arrest in a localized part of the lung.https://doi.org/10.1186/s13023-019-1192-4Congenital pulmonary airways malformationLung malformationsLung developmentProteomics
spellingShingle C. Barazzone-Argiroffo
J. Lascano Maillard
I. Vidal
M. L. Bochaton-Piallat
S. Blaskovic
Y. Donati
B. E. Wildhaber
A.-L. Rougemont
C. Delacourt
I. Ruchonnet-Métrailler
New insights on congenital pulmonary airways malformations revealed by proteomic analyses
Orphanet Journal of Rare Diseases
Congenital pulmonary airways malformation
Lung malformations
Lung development
Proteomics
title New insights on congenital pulmonary airways malformations revealed by proteomic analyses
title_full New insights on congenital pulmonary airways malformations revealed by proteomic analyses
title_fullStr New insights on congenital pulmonary airways malformations revealed by proteomic analyses
title_full_unstemmed New insights on congenital pulmonary airways malformations revealed by proteomic analyses
title_short New insights on congenital pulmonary airways malformations revealed by proteomic analyses
title_sort new insights on congenital pulmonary airways malformations revealed by proteomic analyses
topic Congenital pulmonary airways malformation
Lung malformations
Lung development
Proteomics
url https://doi.org/10.1186/s13023-019-1192-4
work_keys_str_mv AT cbarazzoneargiroffo newinsightsoncongenitalpulmonaryairwaysmalformationsrevealedbyproteomicanalyses
AT jlascanomaillard newinsightsoncongenitalpulmonaryairwaysmalformationsrevealedbyproteomicanalyses
AT ividal newinsightsoncongenitalpulmonaryairwaysmalformationsrevealedbyproteomicanalyses
AT mlbochatonpiallat newinsightsoncongenitalpulmonaryairwaysmalformationsrevealedbyproteomicanalyses
AT sblaskovic newinsightsoncongenitalpulmonaryairwaysmalformationsrevealedbyproteomicanalyses
AT ydonati newinsightsoncongenitalpulmonaryairwaysmalformationsrevealedbyproteomicanalyses
AT bewildhaber newinsightsoncongenitalpulmonaryairwaysmalformationsrevealedbyproteomicanalyses
AT alrougemont newinsightsoncongenitalpulmonaryairwaysmalformationsrevealedbyproteomicanalyses
AT cdelacourt newinsightsoncongenitalpulmonaryairwaysmalformationsrevealedbyproteomicanalyses
AT iruchonnetmetrailler newinsightsoncongenitalpulmonaryairwaysmalformationsrevealedbyproteomicanalyses